Slc35a2 mosaic knockout impacts cortical development, dendritic arborisation, and neuronal firing
- Author(s)
- Spyrou, J; Aung, KP; Vanyai, H; Leventer, RJ; Maljevic, S; Lockhart, PJ; Howell, KB; Reid, CA;
- Journal Title
- Neurobiology of Disease
- Abstract
- Mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE) is an important cause of drug-resistant epilepsy. A significant subset of individuals diagnosed with MOGHE display somatic mosaicism for loss-of-function variants in SLC35A2, which encodes the UDP-galactose transporter. We developed a mouse model to investigate how disruption of this transporter leads to a malformation of cortical development. We used in utero electroporation and CRISPR/Cas9 to knockout Slc35a2 in a subset of layer 2/3 cortical neuronal progenitors in the developing brains of male and female fetal mice to model mosaic expression. Mosaic Slc35a2 knockout was verified through next-generation sequencing and immunohistochemistry of GFP-labelled transfected cells. Histology of brain tissue in mosaic Slc35a2 knockout mice revealed the presence of upper layer-derived cortical neurons in the white matter. Reconstruction of single filled neurons identified altered dendritic arborisation with Slc35a2 knockout neurons having increased complexity. Whole-cell electrophysiological recordings revealed that Slc35a2 knockout neurons display reduced action potential firing, increased afterhyperpolarisation duration and reduced burst-firing when compared with control neurons. Mosaic Slc35a2 knockout mice also exhibited significantly increased epileptiform spiking and increased locomotor activity. We successfully generated a mouse model of mosaic Slc35a2 deficiency, which recapitulates features of the human phenotype, including impaired neuronal migration. We show that knockout in layer 2/3 cortical neuron progenitors is sufficient to disrupt neuronal excitability, increase epileptiform activity and cause hyperactivity in mosaic mice. Our mouse model provides an opportunity to further investigate the disease mechanisms that contribute to MOGHE and facilitate the development of precision therapies.
- Publisher
- Elsevier
- Keywords
- Crispr; Cortical dysplasia; Cortical malformation; Epilepsy; Glycosylation; Neurodevelopment
- Research Division(s)
- Epigenetics And Development
- PubMed ID
- 39236911
- Publisher's Version
- https://doi.org/10.1016/j.nbd.2024.106657
- Open Access at Publisher's Site
https://doi.org/ 10.1016/j.nbd.2024.106657- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-10-03 09:13:29
Last Modified: 2024-10-25 10:50:51